Altasciences Supports 4B Healthcare’s RhineX Clinical Advance
LAVAL, Québec — September 24, 2026 Altasciences announced that its formulation development, manufacturing and quality support for 4B Healthcare...
CRO
Advertisement
Teva Launches LongActingImpact.com for Schizophrenia Care
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
Sling Therapeutics Starts Phase 3 Trial of Linsitinib
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
The Braff Group Advises CCR on PhaseWell Partnership
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
Nuvation Bio Reports Durable IBTROZI Efficacy in ROS1+ NSCLC
New York, New York, U.S., September 15, 2026 Nuvation Bio Inc. has announced new analyses from the pivotal TRUST-I...
Advertisements
Waters Launches BD FACSDiscover A7 Spectral Flow Cytometer
Milford, Massachusetts, U.S., September 14, 2026 Waters Corporation has announced the global commercial launch of the BD FACSDiscover™ A7...
Avance Clinical Wins Australia-Taiwan Business Award
Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...
Labcorp Acquires MLM to Expand Global Clinical Trial Labs
Burlington, North Carolina, USA, September 8, 2026 Labcorp has acquired MLM Medical Labs, strengthening its global central laboratory and...
Prodia the CRO Receives Frost & Sullivan 2026 Customer Value Recognition
SAN ANTONIO — September 8, 2026 PT Prodia Diacro Laboratories (Prodia the CRO) has received Frost & Sullivan’s 2026...
Fortrea to Acquire Worldwide Clinical Trials’ Early Phase Unit
DURHAM, N.C. and RESEARCH TRIANGLE PARK, N.C., September 2, 2026 Fortrea has entered into a definitive agreement to acquire...
Advertisement
